Freeze-dry value on the rise

Complex chemical molecules need complex vehicles for accurate targeting in the body. Increasingly, drug developers are turning to lyophilization as a step in achieving their formulation objectives. Freeze-drying is also growing in importance in manufacturing, thanks to more frequent instances of compounds having low solubility.

Low-solubility issues rear their heads after a compound's initial development stages, says PharmTech. One workaround involves freeze-drying techniques that include organic solvents rather than the more common use of co-solvents, which can complicate formulation.

Freeze-drying techniques--for both formulation and manufacturing--are eligible for patenting and may eventually become part of a company's intellectual property.

- read the article

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.